Explore the latest in dyslipidemia, including recent guidelines for screening and use of statins, PCSK9 inhibitors, and other treatments.
This systematic review to support the 2020 US Preventive Services Task Force Recommendation Statement on behavioral counseling to promote healthy diet and physical activity for cardiovascular disease (CVD) prevention summarizes published evidence on the benefits and harms of behavioral counseling to promote healthy diet and physical activity for CVD prevention in adults with cardiovascular risk factors.
This cohort study assesses 10-year use, adherence, cost, and outcome trends in statin therapy for atherosclerotic cardiovascular disease in US adults using nationwide research center database information.
This cohort study characterizes the relative association of conventional and novel biomarkers in Mediterranean diet–related type 2 diabetes risk reduction in a US population.
This randomized clinical trial assesses the efficacy of α-cyclodextrin for cholesterol control and that of hydrolyzed ginseng for glycemic control in people with prediabetes and overweight or obesity.
This meta-analysis assesses randomized clinical trials of statins to determine the time to benefit for prevention of a first major adverse cardiovascular event in adults aged 50 to 75 years.
This randomized trial examines the effects on cardiovascular outcomes of a carboxylic acid formulation of EPA and DHA (omega-3 CA) with documented favorable effects on lipid and inflammatory markers in patients with atherogenic dyslipidemia and high cardiovascular risk.
This secondary exploratory analysis evaluates the association between baseline low-density lipoprotein cholesterol and the percentage low-density lipoprotein cholesterol reduction with a statin, ezetemibe, and a PCSK9 inhibitor using data from 3 randomized clinical trials
This cohort substudy investigates whether the addition of high-sensitivity troponin level to guideline-derived atherosclerotic cardiovascular disease risk can improve risk classification and downstream treatment recommendations.
This cross-sectional study assesses the within-couple concordance of cardiovascular risk factors and behaviors within couples who participated in a nationwide US employer-sponsored health assessment program.
This randomized clinical trial examines whether 6-month interventions involving different financial incentives to encourage statin adherence reduce low-density lipoprotein cholesterol levels from baseline to 12 months.
This cluster randomized clinical trial evaluates the effect of passive choice and active choice interventions in the electronic health record to promote guideline-directed statin therapy.
This cohort study investigates the association of the national health guidance intervention for obesity and cardiovascular risks with population health outcomes among working-age men in Japan.
This cross-sectional study uses data from the National Disease and Therapeutic Index to quantify changes in volume and type of primary care visits and changes in visit content associated with the COVID-19 pandemic in the US.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: